The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV.
about
Individual-specific ‘fingerprints’ of human DNAEpstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptorsA novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytesX-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus.The Role of Gammaherpesviruses in Cancer PathogenesisAdoptive T-cell therapy for LeukemiaNK Cell Influence on the Outcome of Primary Epstein-Barr Virus InfectionVirus-encoded superantigensThe Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment.Mining human antibody repertoires.Towards therapeutic antibodies to membrane oncoproteins by a robust strategy using rats immunized with transfectants expressing target molecules fused to green fluorescent protein.Epstein-barr virus transformation: involvement of latent membrane protein 1-mediated activation of NF-kappaB.Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakiaExpression of Epstein-Barr virus-encoded small RNA (by the EBER-1 gene) in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease.Comparison of Epstein-Barr virus strains of different origin by analysis of the viral DNAs.DNA of Epstein-Barr virus. V. Direct repeats of the ends of Epstein-Barr virus DNAPresence of Epstein-Barr virus-infected B lymphocytes with thyrotropin receptor antibodies on their surface in Graves' disease patients and in healthy individuals.Comparison between growth characteristics of an Epstein--Barr virus (EBV)-genome-negative lymphoma line and its EBV-converted subline in vitro.Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx.The systemic distribution of Epstein-Barr virus genomes in fatal post-transplantation lymphoproliferative disorders. An in situ hybridization study.Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs.A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1.Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individualsIdentification of type B-specific and cross-reactive cytotoxic T-lymphocyte responses to Epstein-Barr virus.Neoplasms, differentiations and mutations.Are viruses important in carcinogenesis?Lymphocyte transformation induced by autologous cells: stimulation by cultured lymphoblast lines.Normal human B cells display ordered light chain gene rearrangements and deletionsEpstein-Barr virus transformation of human pre-B cells.Studies of lymphokine-activated killer (LAK) cells. I. Evidence using novel monoclonal antibodies that most human LAK precursor cells share a common surface marker.Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.Classification and biological nature of established human hematopoietic cell lines.DNA of Epstein-Barr virus. IV. Linkage map of restriction enzyme fragments of the B95-8 and W91 strains of Epstein-Barr Virus.An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitroEpstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.Epstein-Barr virus recombinants from overlapping cosmid fragments.Immune regulation in Epstein-Barr virus-associated diseasesEpstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.Characterization of Epstein-Barr viral strains in parotid gland saliva and peripheral blood of patients with primary Sjögren's syndrome and healthy EBV carriers.
P2860
Q22122410-4C2622AC-1472-424E-88A6-C17AA81368ECQ24314660-A3C3F376-613A-49F5-8FE2-E8ABA8161892Q24315666-367D0938-3B8A-452C-95AA-08A02C79AB6FQ24517035-05B74ACE-66FD-485B-BF2E-91782095F7E3Q26767186-D0EAD1C4-8A87-4A4C-A094-3ED6EC4E17A9Q27006934-8533FB9E-423B-4F4D-9B81-FDC899538FC8Q28069456-417978BA-5414-448C-B17A-1309EDA3F239Q28776748-6C2A0837-80E0-4452-A756-9DCF4DCADC51Q30278553-6C8AE297-34B3-449E-8340-31B667A878E9Q33588489-BE187FB4-1306-4F49-9C01-69BE14B5CDA8Q33735190-4255B917-11CB-476C-9FCD-180B66D9D3FFQ33797179-C416BE55-057A-4407-ADA1-A76B0AC6181AQ33891606-0757DA69-1DD0-4EED-B276-81745E40632AQ34207259-F7F21AE1-208C-4CE3-8599-1102FC4B5329Q34251907-8ECAF352-F72E-4849-A883-966417D4C645Q34255167-10318E2C-AAAE-4EA2-982B-FFCEC4C12CA0Q34659237-362854CF-C128-4653-B765-3F53C301AC30Q35088713-9AD82143-22B5-4A74-A9C1-6B45BA6877B8Q35119129-F187A296-93FD-46A9-AED7-B09327B5442CQ35830515-3DA1437F-9435-4704-89C0-537CE3E3D580Q35832104-A8CEEA84-7C52-4D8E-8574-34F17DF89859Q35839956-0E0AE578-D9F7-4B68-A219-5A308A7D5384Q35865462-D038BC7F-35C6-4E5D-84D7-6E0E7C2DD3BCQ35873998-385099CD-2F61-476F-898B-A63FB0FC4627Q35875063-456874BF-4FAD-49E6-9025-8B6B244D2907Q35875067-4FDA1C93-993F-4D3F-B52A-F7A45C555674Q35898605-45C6BCC1-833C-49FE-BB1C-4424A1DA670AQ36347007-3425A442-17B9-4CD6-9975-CA3944C1BB6EQ36348967-B84C9148-983C-431A-98F5-23255CE2F327Q36356148-9B8BD2C3-9FE8-4529-9B7D-568094EE3A83Q36399124-A585DB93-BF38-4647-89AC-9466F1B68F79Q36412966-0E8C1D2F-924D-4C08-9F47-6E4F5D875327Q36526302-DBAE439E-278E-47B2-9000-BEC001A3BE75Q36628631-8B7A8D4D-62E5-43A9-85B2-2A3BD1315D69Q36637195-F3A8EF93-40F9-4FDB-95EE-3791CECB6F3CQ36655212-1E48B5A2-F58C-45D5-B238-4AD4FD410EA1Q36669953-3D7DD16C-FA31-4600-B5C5-DBFEFB27E11FQ36686055-992E977E-E4EE-4038-91E8-A50366C1FDC9Q36687455-0332242A-F742-4EC9-BDA9-8BB83E2A14B0Q36742164-1CB29C82-BED5-4237-A035-532E1025400F
P2860
The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV.
description
1971 nî lūn-bûn
@nan
1971年の論文
@ja
1971年学术文章
@wuu
1971年学术文章
@zh-cn
1971年学术文章
@zh-hans
1971年学术文章
@zh-my
1971年学术文章
@zh-sg
1971年學術文章
@yue
1971年學術文章
@zh
1971年學術文章
@zh-hant
name
The establishment of lymphobla ...... sue and its dependence on EBV.
@en
The establishment of lymphobla ...... sue and its dependence on EBV.
@nl
type
label
The establishment of lymphobla ...... sue and its dependence on EBV.
@en
The establishment of lymphobla ...... sue and its dependence on EBV.
@nl
prefLabel
The establishment of lymphobla ...... sue and its dependence on EBV.
@en
The establishment of lymphobla ...... sue and its dependence on EBV.
@nl
P2093
P2860
P356
P1476
The establishment of lymphobla ...... sue and its dependence on EBV.
@en
P2093
P2860
P304
P356
10.1002/IJC.2910080312
P577
1971-11-01T00:00:00Z